𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis

✍ Scribed by Cromwell, Ian; van der Hoek, Kimberly; Malfair Taylor, Suzanne C.; Melosky, Barbara; Peacock, Stuart


Book ID
119320736
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
396 KB
Volume
76
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES